SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-007938
Filing Date
2018-02-13
Accepted
2018-02-13 16:19:29
Documents
9
Period of Report
2018-03-27
Effectiveness Date
2018-02-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv485774_def14a.htm DEF 14A 426703
2 GRAPHIC tv484620_img1.jpg GRAPHIC 56440
3 GRAPHIC image_001.jpg GRAPHIC 49738
4 GRAPHIC image_002.jpg GRAPHIC 74659
5 GRAPHIC image_003.jpg GRAPHIC 30340
6 GRAPHIC image_004.jpg GRAPHIC 13472
7 GRAPHIC image_005.jpg GRAPHIC 84496
8 GRAPHIC image_006.jpg GRAPHIC 87546
9 GRAPHIC image_007.jpg GRAPHIC 54880
  Complete submission text file 0001144204-18-007938.txt   1050524
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: DEF 14A | Act: 34 | File No.: 001-37619 | Film No.: 18603625
SIC: 2834 Pharmaceutical Preparations